Mantra Bio

About:

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

Website: https://mantrabio.com/

Twitter/X: mantrabio

Top Investors: BoxGroup, 8VC, Illumina, Viking Global Investors, SV Angel

Description:

Mantra Bio develops a novel next-generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). The Company's REVEAL platform, which integrates computational and wet biology, and automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics is reproducibly made at high purity.

Total Funding Amount:

$34M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)mantrabio.com

Founders:

Alex Mok, Katie Planey, Terry Gaige

Number of Employees:

11-50

Last Funding Date:

2023-01-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai